These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7016011)

  • 1. Screening for teratogenic hazards: nature of the problems.
    Johnson EM
    Annu Rev Pharmacol Toxicol; 1981; 21():417-29. PubMed ID: 7016011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing.
    Webster WS; Brown-Woodman PD; Ritchie HE
    Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of in vitro procedures in teratology.
    Kochhar DM
    Teratology; 1975 Jun; 11(3):273-87. PubMed ID: 125462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A subvertebrate system for rapid determination of potential teratogenic hazards.
    Johnson EM
    J Environ Pathol Toxicol; 1980 Nov; 4(5-6):153-6. PubMed ID: 7217843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Culture of whole rodent embryos in teratogen screening.
    Fantel AG
    Teratog Carcinog Mutagen; 1982; 2(3-4):231-42. PubMed ID: 6130623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rodent whole-embryo culture as a teratogen screening method.
    Kitchin KT; Schmid BP; Sanyal MK
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):291-301. PubMed ID: 3724303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of postimplantation mammalian embryo culture in the study of teratogenic mechanisms.
    Steele CE
    Prog Clin Biol Res; 1985; 163C():271-6. PubMed ID: 3991630
    [No Abstract]   [Full Text] [Related]  

  • 10. Frog embryo teratogenesis assay on Xenopus and predictivity compared with in vivo mammalian studies.
    Leconte I; Mouche I
    Methods Mol Biol; 2013; 947():403-21. PubMed ID: 23138919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the predictive validity of frog embryo teratogenesis assay-Xenopus (FETAX).
    Fort DJ; Stover EL; Farmer DR; Lemen JK
    Teratog Carcinog Mutagen; 2000; 20(2):87-98. PubMed ID: 10679752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced teratogenesis.
    FRASER FC
    Can Med Assoc J; 1962 Sep; 87(13):683-4. PubMed ID: 13894748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro tests in screening teratogens: considerations to aid the validation process.
    Kimmel GL
    Prog Clin Biol Res; 1985; 163C():259-63. PubMed ID: 3991628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole embryo culture and teratogenesis.
    Steele CE
    Hum Reprod; 1991 Jan; 6(1):144-7. PubMed ID: 1874948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The state and future requirements of teratogenic testing.
    Wendler D
    Arch Toxicol Suppl; 1980; 4():274-83. PubMed ID: 6933916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for teratogenic potential: are we asking the proper question?
    Johnson EM
    Teratology; 1980 Apr; 21(2):259. PubMed ID: 7394727
    [No Abstract]   [Full Text] [Related]  

  • 17. Systematic procedure for the classification of proven and potential teratogens for use in research.
    Eltonsy S; Martin B; Ferreira E; Blais L
    Birth Defects Res A Clin Mol Teratol; 2016 Apr; 106(4):285-97. PubMed ID: 26969841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole embryo culture, teratogenesis, and the estimation of teratologic risk.
    New DA
    Teratology; 1990 Dec; 42(6):635-42. PubMed ID: 2087684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide and the Teratology Society: an awkward marriage.
    Ozolins TR
    Birth Defects Res B Dev Reprod Toxicol; 2010 Aug; 89(4):289-99. PubMed ID: 20803689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Teratology and epidemiology in the study of environmental teratogens].
    Cayré R; Sánchez-Gómez C; Moreno-Rodríguez RA; de la Cruz MV
    Bol Med Hosp Infant Mex; 1992 Jul; 49(7):397-403. PubMed ID: 1418645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.